Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 378, Issue 2, Pages 209-212Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2008.11.028
Keywords
Glyoxalase 1; Methylglyoxal; Protein modification; Cerebral cortex; Development; Argpyrimidine; Advanced glycation end products
Categories
Ask authors/readers for more resources
Methylglyoxal (MG) is an endogenous metabolite in glycolysis and forms stable adducts primarily with arginine residues of intracellular proteins. The biological role of this modification in cell function is not known. In the present study, we found that a MG-detoxification enzyme glyoxalase I (GLO1) is mainly expressed in the ventricular zone (VZ) at embryonic clay 16 which neural stein and progenitor cells localize. Moreover, immunohistochemical analysis revealed that argpyrimidine, a major MG-arginine adduct, is predominantly produced in cortical plate neurons not VZ during cerebral Cortex development and is exclusively located in the nucleus. Immunoblotting experiment showed that the formation of argpyrimidine occurs oil some nuclear proteins of cortical neurons. To our knowledge, this is first report of the argpyrimidine formation in the nucleus of neuron. These findings Suggest that GLO1, which is dominantly expressed in the embryonic VZ, reduces the intracellular level of MG and Suppresses the formation of argpyrimidine in neural stern and progenitor cells. Argpyrimidine May contribute to the neural differentiation and/or the maintenance of the differentiated state via the modification of nuclear proteins. (C) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available